COMPREHENSIVE ACCESS AND SUPPORT
Most affordable NOAC:
lowest average out-of-pocket cost1
FORMULARY COVERAGE WITH XARELTO®
Janssen is dedicated to making XARELTO® affordable and accessible for all patients. With widespread inclusion on hospital, managed care, and PBM formularies, >95% of commercial and >90% Medicare Part D patients are covered at the lowest branded co-pay.2
To see the formulary coverage for your patients, enter your ZIP code. Your results will appear below.
JANSSEN CAREPATH FOR XARELTO®
Copay as low as $10 every month* for eligible patients with commercial insurance
- Eligible patients with an approved chronic indication for XARELTO®
- $3400 maximum program benefit per calendar year, subject to monthly limits
- Not valid for patients using Medicare, Medicare Part D, Medicaid, or other government-funded programs
SUPPORT FOR PATIENTS USING GOVERNMENT INSURANCE OR PATIENTS WITHOUT INSURANCE COVERAGE
JANSSEN PRESCRIPTION ASSISTANCE FOR XARELTO®
- Provides information on affordability options including information about independent foundations that may have available funding to help minimize drug costs for XARELTO®
For more information, visit Janssen Prescription Assistance
The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is an independent, nonprofit organization that is committed to helping eligible patients without insurance coverage receive prescription products donated by Johnson & Johnson operating companies. To see if they might qualify for assistance, please have your patient contact a JJPAF program specialist at 1-800-652-6227 (9 AM to 6 PM ET) or visit the foundation website at www.JJPAF.org.
◇For VTE prophylaxis in acutely ill medical patients at risk for thromboembolic complications who are not at high risk of bleeding.
DOAC = direct oral anticoagulant; NOAC = non-vitamin K antagonist oral anticoagulant.
*Month = 30-day fill.